$IVVD 4 SEC Filings

Filed On	Filing
02 Sep 2026	Form 4: Sheffield Ian, Director Granted 100,000 Stock Option (Right to Buy)
01 Sep 2026	Form 4: Elia Marc, Director Granted 10,700,000 Stock Option (Right to Buy)
18 Aug 2026	Form 4: Lee Timothy Edward, Chief Commercial Officer Received 102,000 shares by exercise or conversion · Sold 22,355 shares ($16.1K) · Sold 18,425 shares ($15.5K)
18 Aug 2026	Form 4: Green Julie, Chief Human Resources Officer Received 102,000 shares by exercise or conversion · Sold 22,355 shares ($16.1K) · Sold 18,425 shares ($15.5K)
18 Aug 2026	Form 4: Duke William E., Chief Financial Officer Received 102,000 shares by exercise or conversion · Sold 22,355 shares ($16.1K) · Sold 18,425 shares ($15.5K)
18 Aug 2026	Form 4: Andersen Jill, Chief Legal Officer, Secretary Received 170,000 shares by exercise or conversion · Sold 37,256 shares ($26.9K) · Sold 30,706 shares ($25.9K)
18 Aug 2026	Form 4: Allen Robert D. Iii, Chief Scientific Officer Received 102,000 shares by exercise or conversion · Sold 20,679 shares ($14.9K) · Sold 17,043 shares ($14.4K)
04 Aug 2026	Form 4: Mina Michael, CMO and Chief Epidemiologist Granted 1,125,000 Stock Option (Right to Buy)
21 May 2026	Form 4: Royan Ajay, Director Granted 50,000 Stock Option (Right to Buy)
21 May 2026	Form 4: Mclaughlin Kevin F, Director Granted 50,000 Stock Option (Right to Buy)
21 May 2026	Form 4: Mcguire Terrance, Director Granted 50,000 Stock Option (Right to Buy)
21 May 2026	Form 4: Elia Marc, Director and 1 other Granted 50,000 Stock Option (Right to Buy)
21 May 2026	Form 4: Bolno Paul, Director Granted 32,876 Stock Option (Right to Buy)
21 May 2026	Form 4: Berry Tamsin, Director Granted 50,000 Stock Option (Right to Buy)
18 Feb 2026	Form 4: Allen Robert D. Iii, Chief Scientific Officer Received 99,000 shares by exercise or conversion · Sold 18,189 shares ($28K) · Sold 19,392 shares ($30.6K)
18 Feb 2026	Form 4: Green Julie, Chief Human Resources Officer Received 99,000 shares by exercise or conversion · Sold 19,663 shares ($30.3K) · Sold 20,964 shares ($33.1K)
18 Feb 2026	Form 4: Duke William E., Chief Financial Officer Received 99,000 shares by exercise or conversion · Sold 19,663 shares ($30.3K) · Sold 20,964 shares ($33.1K)
18 Feb 2026	Form 4: Lee Timothy Edward, Chief Commercial Officer Received 99,000 shares by exercise or conversion · Sold 19,663 shares ($30.3K) · Sold 20,964 shares ($33.1K)
18 Feb 2026	Form 4: Andersen Jill, Chief Legal Officer, Secretary Received 165,000 shares by exercise or conversion · Sold 32,771 shares ($50.5K) · Sold 34,939 shares ($55.1K)
30 Jan 2026	Form 4: Duke William E., Chief Financial Officer Granted 625,000 Stock Option (Right to Buy)

Comments